The risk of thrombosis in patients with systemic lupus erythematosus is increased by several factors, including older age at onset, antiphospholipid antibody (aPL) positivity, and history of nephritis, investigators report. Reuters Health Information
Read this study to learn about the increasing role of biologic therapies in the treatment of rheumatoid arthritis. International Journal of Clinical Rheumatology
Ambrisentan, a diphenyl propionic acid derivative, represents a valuable addition to the treatment alternatives for this orphan disease AccessMedicine from McGraw-Hill
The past decade has witnessed a revolution in osteoporosis diagnosis and treatment and the next decade promises even greater advances. Arthritis Research & Therapy
